How the healthcare industry is reacting to a second Trump term (Medtech Dive)

Republican candidate and former president Donald Trump was elected to a second term, signaling a possible return to healthcare policies from his first term, with anticipated regulatory changes impacting the ACA, Medicaid, and vaccine policies. Trump’s administration may seek to reduce costs by limiting ACA subsidies, potentially increasing uninsured rates, and revisit Medicaid restrictions like work requirements. Trump’s support for vaccine skeptic Robert F. Kennedy Jr. raises questions about potential public health changes, while experts foresee a rollback on gender-affirming care and tighter access to abortion services. Major healthcare industry groups, including the American Hospital Association, America’s Essential Hospitals, and the American Telemedicine Association, have expressed readiness to collaborate with the incoming administration to address pressing issues, including telehealth expansion and affordable healthcare access, while insurer groups largely withheld comments.